Brian Kann, MD
Colon & Rectal Surgery · New Orleans, LANPI 1689763179
Payments from drug & device makers
What this record shows
15 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 57.7% of the total. Reporting peaked in 2020 at $2,891 and has fallen 85.3% since, to $425 in 2025.
Across 51 payments — averaging $195.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$6K
- Biom'up France SAS$842
- Johnson & Johnson$650
- Biom'up SA$630
- Medtronic$533
- Pentax Of America, Inc.$243
- plus $1K from 9 others
What the payments were for
- Speaking & faculty fees$5,76558%
- Food & beverage$4,22042%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $5,765 |
| Biom'up France SAS | 9 | $842 |
| Johnson & Johnson | 7 | $650 |
| Biom'up SA | 8 | $630 |
| Medtronic(2 entities) | 7 | $533 |
| Pentax Of America, Inc. | 1 | $243 |
| Kerecis Limited | 1 | $232 |
| Dilon Technologies, Inc. | 3 | $203 |
| AbbVie | 2 | $168 |
| Boston Scientific | 2 | $165 |
| Axonics, Inc. | 1 | $150 |
| Guard Medical Inc. | 1 | $139 |
| ERBE USA Inc | 1 | $125 |
| Davol Inc. | 1 | $111 |
| Vertex | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GATTEX$5,765
- HemoBlast Bellows$779
- Kerecis Omega3 SurgiClose$697
- PENTAX Medical$485
- HEMOBLAST$359
- INSPIRA$243
- C2 CryoBalloon Focal Controller$243
- C2 Cryoballoon$243
- Kerecis Omega3 GraftGuide$232
- Kerecis Omega3 Marigen$232
- INTERSTIM$163
- Axonics$150
- Situate$146
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$145
- ETHICON$142
- NPSEAL LARGE$139
- ERBE$125
- VISTASEAL$122
- INTERSTIM ICON$114
- Phasix Mesh$111
How this compares
$9,985 in reported general payments places this provider in the 65th percentile of 39 colon & rectal surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 31 | $2,123 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 55 | $996 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 32 | $614 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 17 | $322 |
| Oxycodone Hcl | 14 | $77 |
| Metronidazole | 19 | $50 |
| Ciprofloxacin Hcl | 18 | $38 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in New Orleans
- Jennifer ParuchNew Orleans$63K
- Charles WhitlowNew Orleans$22K
- Elyse Bevier-RawlsNew Orleans$18K
- Danielle KayNew Orleans$16K
- William JohnstonNew Orleans$15K
- Valentine NfonsamNew Orleans$15K
- Guy OrangioNew Orleans$4K
- Herschel VargasNew Orleans$2K
- Lindsey GadeNew Orleans$2K
- Danielle DooleyNew Orleans$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.